Mayne Pharma 2024 Full Year Results Media Release
Mayne Pharma’s CEO, Mr Shawn Patrick O’Brien said “Mayne Pharma has delivered a significant improvement in Group performance, achieving all five key operating metrics including a positive direct contribution from all three business segments and a positive underlying EBITDA in FY24.”
Learn more